The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gadopentetate Dimeglumine Market Research Report 2025
Synopsis
The global Gadopentetate Dimeglumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadopentetate Dimeglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadopentetate Dimeglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadopentetate Dimeglumine include Bayer, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical and BeiLu Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadopentetate Dimeglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadopentetate Dimeglumine.
Report Scope
The Gadopentetate Dimeglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadopentetate Dimeglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadopentetate Dimeglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
BeiLu Pharma
Segment by Type
10ml: 4.69g
12ml: 5.63g
15ml: 7.04g
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadopentetate Dimeglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadopentetate Dimeglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Gadopentetate Dimeglumine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gadopentetate Dimeglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gadopentetate Dimeglumine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gadopentetate Dimeglumine include Bayer, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical and BeiLu Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gadopentetate Dimeglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadopentetate Dimeglumine.
Report Scope
The Gadopentetate Dimeglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gadopentetate Dimeglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadopentetate Dimeglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
BeiLu Pharma
Segment by Type
10ml: 4.69g
12ml: 5.63g
15ml: 7.04g
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gadopentetate Dimeglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gadopentetate Dimeglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gadopentetate Dimeglumine Market Overview
1.1 Product Overview and Scope of Gadopentetate Dimeglumine
1.2 Gadopentetate Dimeglumine Segment by Type
1.2.1 Global Gadopentetate Dimeglumine Market Value Comparison by Type (2024-2030)
1.2.2 10ml: 4.69g
1.2.3 12ml: 5.63g
1.2.4 15ml: 7.04g
1.2.5 Others
1.3 Gadopentetate Dimeglumine Segment by Application
1.3.1 Global Gadopentetate Dimeglumine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadopentetate Dimeglumine Market Size Estimates and Forecasts
1.4.1 Global Gadopentetate Dimeglumine Revenue 2019-2030
1.4.2 Global Gadopentetate Dimeglumine Sales 2019-2030
1.4.3 Global Gadopentetate Dimeglumine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gadopentetate Dimeglumine Market Competition by Manufacturers
2.1 Global Gadopentetate Dimeglumine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gadopentetate Dimeglumine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gadopentetate Dimeglumine Average Price by Manufacturers (2019-2024)
2.4 Global Gadopentetate Dimeglumine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadopentetate Dimeglumine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadopentetate Dimeglumine, Product Type & Application
2.7 Gadopentetate Dimeglumine Market Competitive Situation and Trends
2.7.1 Gadopentetate Dimeglumine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gadopentetate Dimeglumine Players Market Share by Revenue
2.7.3 Global Gadopentetate Dimeglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadopentetate Dimeglumine Retrospective Market Scenario by Region
3.1 Global Gadopentetate Dimeglumine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gadopentetate Dimeglumine Global Gadopentetate Dimeglumine Sales by Region: 2019-2030
3.2.1 Global Gadopentetate Dimeglumine Sales by Region: 2019-2024
3.2.2 Global Gadopentetate Dimeglumine Sales by Region: 2025-2030
3.3 Global Gadopentetate Dimeglumine Global Gadopentetate Dimeglumine Revenue by Region: 2019-2030
3.3.1 Global Gadopentetate Dimeglumine Revenue by Region: 2019-2024
3.3.2 Global Gadopentetate Dimeglumine Revenue by Region: 2025-2030
3.4 North America Gadopentetate Dimeglumine Market Facts & Figures by Country
3.4.1 North America Gadopentetate Dimeglumine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gadopentetate Dimeglumine Sales by Country (2019-2030)
3.4.3 North America Gadopentetate Dimeglumine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadopentetate Dimeglumine Market Facts & Figures by Country
3.5.1 Europe Gadopentetate Dimeglumine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gadopentetate Dimeglumine Sales by Country (2019-2030)
3.5.3 Europe Gadopentetate Dimeglumine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadopentetate Dimeglumine Market Facts & Figures by Country
3.6.1 Asia Pacific Gadopentetate Dimeglumine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gadopentetate Dimeglumine Sales by Country (2019-2030)
3.6.3 Asia Pacific Gadopentetate Dimeglumine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadopentetate Dimeglumine Market Facts & Figures by Country
3.7.1 Latin America Gadopentetate Dimeglumine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gadopentetate Dimeglumine Sales by Country (2019-2030)
3.7.3 Latin America Gadopentetate Dimeglumine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadopentetate Dimeglumine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gadopentetate Dimeglumine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gadopentetate Dimeglumine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gadopentetate Dimeglumine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadopentetate Dimeglumine Sales by Type (2019-2030)
4.1.1 Global Gadopentetate Dimeglumine Sales by Type (2019-2024)
4.1.2 Global Gadopentetate Dimeglumine Sales by Type (2025-2030)
4.1.3 Global Gadopentetate Dimeglumine Sales Market Share by Type (2019-2030)
4.2 Global Gadopentetate Dimeglumine Revenue by Type (2019-2030)
4.2.1 Global Gadopentetate Dimeglumine Revenue by Type (2019-2024)
4.2.2 Global Gadopentetate Dimeglumine Revenue by Type (2025-2030)
4.2.3 Global Gadopentetate Dimeglumine Revenue Market Share by Type (2019-2030)
4.3 Global Gadopentetate Dimeglumine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gadopentetate Dimeglumine Sales by Application (2019-2030)
5.1.1 Global Gadopentetate Dimeglumine Sales by Application (2019-2024)
5.1.2 Global Gadopentetate Dimeglumine Sales by Application (2025-2030)
5.1.3 Global Gadopentetate Dimeglumine Sales Market Share by Application (2019-2030)
5.2 Global Gadopentetate Dimeglumine Revenue by Application (2019-2030)
5.2.1 Global Gadopentetate Dimeglumine Revenue by Application (2019-2024)
5.2.2 Global Gadopentetate Dimeglumine Revenue by Application (2025-2030)
5.2.3 Global Gadopentetate Dimeglumine Revenue Market Share by Application (2019-2030)
5.3 Global Gadopentetate Dimeglumine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Gadopentetate Dimeglumine Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Gadopentetate Dimeglumine Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Fuji Pharma
6.3.1 Fuji Pharma Corporation Information
6.3.2 Fuji Pharma Description and Business Overview
6.3.3 Fuji Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fuji Pharma Gadopentetate Dimeglumine Product Portfolio
6.3.5 Fuji Pharma Recent Developments/Updates
6.4 Towaseiyaku
6.4.1 Towaseiyaku Corporation Information
6.4.2 Towaseiyaku Description and Business Overview
6.4.3 Towaseiyaku Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Towaseiyaku Gadopentetate Dimeglumine Product Portfolio
6.4.5 Towaseiyaku Recent Developments/Updates
6.5 Hikari Pharmaceutical
6.5.1 Hikari Pharmaceutical Corporation Information
6.5.2 Hikari Pharmaceutical Description and Business Overview
6.5.3 Hikari Pharmaceutical Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikari Pharmaceutical Gadopentetate Dimeglumine Product Portfolio
6.5.5 Hikari Pharmaceutical Recent Developments/Updates
6.6 BeiLu Pharma
6.6.1 BeiLu Pharma Corporation Information
6.6.2 BeiLu Pharma Description and Business Overview
6.6.3 BeiLu Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BeiLu Pharma Gadopentetate Dimeglumine Product Portfolio
6.6.5 BeiLu Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadopentetate Dimeglumine Industry Chain Analysis
7.2 Gadopentetate Dimeglumine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadopentetate Dimeglumine Production Mode & Process
7.4 Gadopentetate Dimeglumine Sales and Marketing
7.4.1 Gadopentetate Dimeglumine Sales Channels
7.4.2 Gadopentetate Dimeglumine Distributors
7.5 Gadopentetate Dimeglumine Customers
8 Gadopentetate Dimeglumine Market Dynamics
8.1 Gadopentetate Dimeglumine Industry Trends
8.2 Gadopentetate Dimeglumine Market Drivers
8.3 Gadopentetate Dimeglumine Market Challenges
8.4 Gadopentetate Dimeglumine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gadopentetate Dimeglumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gadopentetate Dimeglumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gadopentetate Dimeglumine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gadopentetate Dimeglumine Sales (K L) of Key Manufacturers (2019-2024)
Table 5. Global Gadopentetate Dimeglumine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gadopentetate Dimeglumine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gadopentetate Dimeglumine Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gadopentetate Dimeglumine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gadopentetate Dimeglumine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gadopentetate Dimeglumine, Product Type & Application
Table 12. Global Key Manufacturers of Gadopentetate Dimeglumine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gadopentetate Dimeglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadopentetate Dimeglumine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gadopentetate Dimeglumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gadopentetate Dimeglumine Sales by Region (2019-2024) & (K L)
Table 18. Global Gadopentetate Dimeglumine Sales Market Share by Region (2019-2024)
Table 19. Global Gadopentetate Dimeglumine Sales by Region (2025-2030) & (K L)
Table 20. Global Gadopentetate Dimeglumine Sales Market Share by Region (2025-2030)
Table 21. Global Gadopentetate Dimeglumine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gadopentetate Dimeglumine Revenue Market Share by Region (2019-2024)
Table 23. Global Gadopentetate Dimeglumine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gadopentetate Dimeglumine Revenue Market Share by Region (2025-2030)
Table 25. North America Gadopentetate Dimeglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gadopentetate Dimeglumine Sales by Country (2019-2024) & (K L)
Table 27. North America Gadopentetate Dimeglumine Sales by Country (2025-2030) & (K L)
Table 28. North America Gadopentetate Dimeglumine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gadopentetate Dimeglumine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gadopentetate Dimeglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gadopentetate Dimeglumine Sales by Country (2019-2024) & (K L)
Table 32. Europe Gadopentetate Dimeglumine Sales by Country (2025-2030) & (K L)
Table 33. Europe Gadopentetate Dimeglumine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gadopentetate Dimeglumine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gadopentetate Dimeglumine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gadopentetate Dimeglumine Sales by Region (2019-2024) & (K L)
Table 37. Asia Pacific Gadopentetate Dimeglumine Sales by Region (2025-2030) & (K L)
Table 38. Asia Pacific Gadopentetate Dimeglumine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gadopentetate Dimeglumine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gadopentetate Dimeglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gadopentetate Dimeglumine Sales by Country (2019-2024) & (K L)
Table 42. Latin America Gadopentetate Dimeglumine Sales by Country (2025-2030) & (K L)
Table 43. Latin America Gadopentetate Dimeglumine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gadopentetate Dimeglumine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gadopentetate Dimeglumine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gadopentetate Dimeglumine Sales by Country (2019-2024) & (K L)
Table 47. Middle East & Africa Gadopentetate Dimeglumine Sales by Country (2025-2030) & (K L)
Table 48. Middle East & Africa Gadopentetate Dimeglumine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gadopentetate Dimeglumine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gadopentetate Dimeglumine Sales (K L) by Type (2019-2024)
Table 51. Global Gadopentetate Dimeglumine Sales (K L) by Type (2025-2030)
Table 52. Global Gadopentetate Dimeglumine Sales Market Share by Type (2019-2024)
Table 53. Global Gadopentetate Dimeglumine Sales Market Share by Type (2025-2030)
Table 54. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gadopentetate Dimeglumine Revenue Market Share by Type (2019-2024)
Table 57. Global Gadopentetate Dimeglumine Revenue Market Share by Type (2025-2030)
Table 58. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2019-2024)
Table 59. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2025-2030)
Table 60. Global Gadopentetate Dimeglumine Sales (K L) by Application (2019-2024)
Table 61. Global Gadopentetate Dimeglumine Sales (K L) by Application (2025-2030)
Table 62. Global Gadopentetate Dimeglumine Sales Market Share by Application (2019-2024)
Table 63. Global Gadopentetate Dimeglumine Sales Market Share by Application (2025-2030)
Table 64. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gadopentetate Dimeglumine Revenue Market Share by Application (2019-2024)
Table 67. Global Gadopentetate Dimeglumine Revenue Market Share by Application (2025-2030)
Table 68. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2019-2024)
Table 69. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Bayer Gadopentetate Dimeglumine Product
Table 74. Bayer Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. Takeda Gadopentetate Dimeglumine Product
Table 79. Takeda Recent Developments/Updates
Table 80. Fuji Pharma Corporation Information
Table 81. Fuji Pharma Description and Business Overview
Table 82. Fuji Pharma Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Fuji Pharma Gadopentetate Dimeglumine Product
Table 84. Fuji Pharma Recent Developments/Updates
Table 85. Towaseiyaku Corporation Information
Table 86. Towaseiyaku Description and Business Overview
Table 87. Towaseiyaku Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Towaseiyaku Gadopentetate Dimeglumine Product
Table 89. Towaseiyaku Recent Developments/Updates
Table 90. Hikari Pharmaceutical Corporation Information
Table 91. Hikari Pharmaceutical Description and Business Overview
Table 92. Hikari Pharmaceutical Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. Hikari Pharmaceutical Gadopentetate Dimeglumine Product
Table 94. Hikari Pharmaceutical Recent Developments/Updates
Table 95. BeiLu Pharma Corporation Information
Table 96. BeiLu Pharma Description and Business Overview
Table 97. BeiLu Pharma Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. BeiLu Pharma Gadopentetate Dimeglumine Product
Table 99. BeiLu Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Gadopentetate Dimeglumine Distributors List
Table 103. Gadopentetate Dimeglumine Customers List
Table 104. Gadopentetate Dimeglumine Market Trends
Table 105. Gadopentetate Dimeglumine Market Drivers
Table 106. Gadopentetate Dimeglumine Market Challenges
Table 107. Gadopentetate Dimeglumine Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gadopentetate Dimeglumine
Figure 2. Global Gadopentetate Dimeglumine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gadopentetate Dimeglumine Market Share by Type in 2023 & 2030
Figure 4. 10ml: 4.69g Product Picture
Figure 5. 12ml: 5.63g Product Picture
Figure 6. 15ml: 7.04g Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gadopentetate Dimeglumine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Gadopentetate Dimeglumine Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Global Gadopentetate Dimeglumine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gadopentetate Dimeglumine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Gadopentetate Dimeglumine Sales (2019-2030) & (K L)
Figure 15. Global Gadopentetate Dimeglumine Average Price (US$/L) & (2019-2030)
Figure 16. Gadopentetate Dimeglumine Report Years Considered
Figure 17. Gadopentetate Dimeglumine Sales Share by Manufacturers in 2023
Figure 18. Global Gadopentetate Dimeglumine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Gadopentetate Dimeglumine Players: Market Share by Revenue in 2023
Figure 20. Gadopentetate Dimeglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Gadopentetate Dimeglumine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Gadopentetate Dimeglumine Sales Market Share by Country (2019-2030)
Figure 23. North America Gadopentetate Dimeglumine Revenue Market Share by Country (2019-2030)
Figure 24. United States Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Gadopentetate Dimeglumine Sales Market Share by Country (2019-2030)
Figure 27. Europe Gadopentetate Dimeglumine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Gadopentetate Dimeglumine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Gadopentetate Dimeglumine Revenue Market Share by Region (2019-2030)
Figure 35. China Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Gadopentetate Dimeglumine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Gadopentetate Dimeglumine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Gadopentetate Dimeglumine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Gadopentetate Dimeglumine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Gadopentetate Dimeglumine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Gadopentetate Dimeglumine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Gadopentetate Dimeglumine by Type (2019-2030)
Figure 56. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2019-2030)
Figure 57. Global Sales Market Share of Gadopentetate Dimeglumine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Gadopentetate Dimeglumine by Application (2019-2030)
Figure 59. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2019-2030)
Figure 60. Gadopentetate Dimeglumine Value Chain
Figure 61. Gadopentetate Dimeglumine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
